首页> 外文期刊>Gastrointestinal Endoscopy >Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
【24h】

Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.

机译:食管恶性黑色素瘤局部注射干扰素β作为全身性DAV化疗前后的佐剂:病例报告具有7年的长期生存率。

获取原文
获取原文并翻译 | 示例
           

摘要

Primary malignant melanoma of the esophagus (PMME) is a very rare and deadly disease. We report a case of a 64-year-old Japanese woman who was diagnosed by histology, after endoscopy, as having a primary malignant melanoma. A novel approach that consisted of pre- and postoperative dacarbazine-nimustine-vincristine (DAV)-feron therapy with dacarbazine (DTIC), nimustine (ACNU), vincristine (VCR), and interferon beta (INF-beta), in conjunction with radical esophagectomy, was used. The tumor invaded the sub-mucosal layer, with cervical-node involvement. During a postoperative 7 years of follow-up, no evidence of local recurrence or metastasis was found. The possibility that the combination of chemo-feron therapy, including endo-scopic local injection and radical esophagectomy, will improve the prognosis for patients with PMME is suggested.
机译:食管原发性恶性黑色素瘤是一种非常罕见且致命的疾病。我们报道了一例64岁的日本女性,经内镜检查经组织学诊断为原发性恶性黑色素瘤。一种由达卡巴嗪(DTIC),尼莫斯汀(ACNU),长春新碱(VCR)和干扰素beta(INF-beta)联合根治性手术前后的达卡巴嗪-尼莫斯汀-长春新碱(DAV)-feron疗法组成的新方法使用食管切除术。肿瘤侵犯了粘膜下层,并累及宫颈淋巴结。在术后7年的随访中,未发现任何局部复发或转移的证据。提示内镜下局部注射和根治性食管切除术联合化学-铁疗法可能会改善PMME患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号